Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis.
- Resource Type
- Article
- Authors
- Samadder, N. Jewel; Foster, Nathan; McMurray, Ryan P.; Burke, Carol A.; Stoffel, Elena; Kanth, Priyanka; Das, Rohit; Correa, Marcia Cruz; Vilar, E.; Mankaney, Gautam; Buttar, Navtej; Thirumurthi, Selvi; Turgeon, Danielle K.; Sossenheimer, Michael; Westover, Michelle; Richmond, Ellen; Umar, Asad; Della'Zanna, Gary; Rodriguez, Luz M.; Szabo, Eva
- Source
- Gut; Feb2023, Vol. 72 Issue 2, p256-263, 8p
- Subject
- ADENOMATOUS polyposis coli
ADENOMATOUS polyps
ERLOTINIB
POLYPS
- Language
- ISSN
- 00175749